Literature DB >> 19906942

Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins.

Shingo Takikawa1, Ronald E Engle, Kristina N Faulk, Suzanne U Emerson, Robert H Purcell, Jens Bukh.   

Abstract

GB virus B (GBV-B) causes acute hepatitis in experimentally infected tamarins. We compared evolutionary features in acute resolving and persistent GBV-B infection. We detected no evidence of evolution in four animals with clearance during weeks 9-12, whereas three animals with clearance during weeks 13-26 had several substitutions in their polyprotein sequence. A single tamarin had long-term GBV-B viraemia; analysis of virus recovered at weeks 2, 5, 12, 20, 26, 52 and 104 demonstrated that mutations accumulated over time. Overall, the amino acid substitution rate was 3.5x10(-3) and 1.1x10(-3) substitutions per site year(-1) during weeks 1-52 and 53-104, respectively. Thus, there was a significant decrease in evolution over time, as found for hepatitis C virus. The rate of non-synonymous substitution per non-synonymous site compared with that of synonymous substitution per synonymous site decreased over time, suggesting reduction of positive selective pressure. These data demonstrate that prolonged GBV-B infection is associated with viral evolution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906942      PMCID: PMC2888096          DOI: 10.1099/vir.0.015750-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.

Authors:  S J Polyak; K S Khabar; M Rezeiq; D R Gretch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Acute GB virus B infection of marmosets is accompanied by mutations in the NS5A protein.

Authors:  Karen K Kyuregyan; Valentina F Poleschuk; Natalya A Zamyatina; Olga V Isaeva; Michail I Michailov; Stefan Ross; Jens Bukh; Michael Roggendorf; Sergei Viazov
Journal:  Virus Res       Date:  2005-07-28       Impact factor: 3.303

3.  Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.

Authors:  X Forns; R Thimme; S Govindarajan; S U Emerson; R H Purcell; F V Chisari; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

4.  Restricted quasispecies variation following infection with the GB virus B.

Authors:  Michael Joseph McGarvey; Mohammed Iqbal; Theodoros Nastos; Peter Karayiannis
Journal:  Virus Res       Date:  2008-05-01       Impact factor: 3.303

5.  Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity.

Authors:  Javier Fernandez; Deborah Taylor; Duncan R Morhardt; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Stephen M Feinstone; Marian E Major
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein.

Authors:  Shingo Takikawa; Ronald E Engle; Suzanne U Emerson; Robert H Purcell; Marisa St Claire; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 7.  A critical role for the chimpanzee model in the study of hepatitis C.

Authors:  Jens Bukh
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

8.  In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin.

Authors:  Jae-Hwan Nam; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Marisa St Claire; Jens Bukh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived.

Authors:  Jens Bukh; Ronald E Engle; Sugantha Govindarajan; Robert H Purcell
Journal:  J Med Virol       Date:  2008-01       Impact factor: 2.327

10.  Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA.

Authors:  Annette Martin; Francis Bodola; David V Sangar; Kathryn Goettge; Vsevolod Popov; Rene Rijnbrand; Robert E Lanford; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-07       Impact factor: 11.205

View more
  12 in total

Review 1.  Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses.

Authors:  Troels K H Scheel; Peter Simmonds; Amit Kapoor
Journal:  Antiviral Res       Date:  2014-12-26       Impact factor: 5.970

2.  NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies.

Authors:  Célia Boukadida; Caroline Marnata; Roland Montserret; Lisette Cohen; Brigitte Blumen; Jérôme Gouttenoire; Darius Moradpour; François Penin; Annette Martin
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

Review 3.  Animal models for the study of HCV.

Authors:  Koen Vercauteren; Ype P de Jong; Philip Meuleman
Journal:  Curr Opin Virol       Date:  2015-05-23       Impact factor: 7.090

Review 4.  Animal Models of Hepatitis C Virus Infection.

Authors:  Alexander Ploss; Amit Kapoor
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

5.  Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.

Authors:  Caroline Marnata; Aure Saulnier; Dimitri Mompelat; Thomas Krey; Lisette Cohen; Célia Boukadida; Lucile Warter; Judith Fresquet; Ieva Vasiliauskaite; Nicolas Escriou; François-Loïc Cosset; Felix A Rey; Robert E Lanford; Peter Karayiannis; Nicola J Rose; Dimitri Lavillette; Annette Martin
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

6.  A novel hepacivirus with an unusually long and intrinsically disordered NS5A protein in a wild Old World primate.

Authors:  Michael Lauck; Samuel D Sibley; James Lara; Michael A Purdy; Yury Khudyakov; David Hyeroba; Alex Tumukunde; Geoffrey Weny; William M Switzer; Colin A Chapman; Austin L Hughes; Thomas C Friedrich; David H O'Connor; Tony L Goldberg
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

7.  Characterization of natural killer cells in tamarins: a technical basis for studies of innate immunity.

Authors:  Tomoyuki Yoshida; Akatsuki Saito; Yuki Iwasaki; Sayuki Iijima; Terue Kurosawa; Yuko Katakai; Yasuhiro Yasutomi; Keith A Reimann; Toshiyuki Hayakawa; Hirofumi Akari
Journal:  Front Microbiol       Date:  2010-12-08       Impact factor: 5.640

8.  Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets.

Authors:  Yuki Iwasaki; Ken-Ichi Mori; Koji Ishii; Noboru Maki; Sayuki Iijima; Tomoyuki Yoshida; Sachi Okabayashi; Yuko Katakai; Young-Jung Lee; Akatsuki Saito; Hiromi Fukai; Nobuyuki Kimura; Naohide Ageyama; Sayaka Yoshizaki; Tetsuro Suzuki; Yasuhiro Yasutomi; Tatsuo Miyamura; Mari Kannagi; Hirofumi Akari
Journal:  Front Microbiol       Date:  2011-12-07       Impact factor: 5.640

9.  NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities.

Authors:  Célia Boukadida; Matthieu Fritz; Brigitte Blumen; Marie-Laure Fogeron; François Penin; Annette Martin
Journal:  PLoS Pathog       Date:  2018-02-07       Impact factor: 6.823

Review 10.  Animal Models to Study Hepatitis C Virus Infection.

Authors:  Rani Burm; Laura Collignon; Ahmed Atef Mesalam; Philip Meuleman
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.